scispace - formally typeset
W

Willis Akhwale

Publications -  37
Citations -  2860

Willis Akhwale is an academic researcher. The author has contributed to research in topics: Malaria & Population. The author has an hindex of 26, co-authored 37 publications receiving 2679 citations.

Papers
More filters
Journal ArticleDOI

The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial

TL;DR: In resource-limited settings, malaria control programmes should consider use of text messaging to improve health workers' case-management practices and correct artemether-lumefantrine management improved.
Journal ArticleDOI

Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control.

TL;DR: Re-analysis of existing data suggests that co-infection with P. falciparum and hookworm has an additive impact on hemoglobin, exacerbating anemia-related malarial disease burden and it is suggested that both school-age children and pregnant women would benefit from an integrated approach to malaria and helminth control.
Journal ArticleDOI

Increasing Coverage and Decreasing Inequity in Insecticide-Treated Bed Net Use among Rural Kenyan Children

TL;DR: Rapid scaling up of ITN coverage among Africa's poorest rural children can be achieved through mass distribution campaigns, and each complimentary approach should aim to make this intervention free to clients to ensure equitable access.
Journal ArticleDOI

Effect of expanded insecticide-treated bednet coverage on child survival in rural Kenya: a longitudinal study

TL;DR: A combined approach of social marketing followed by mass free distribution of ITNs translated into child survival effects that are comparable with those seen in previous randomised controlled trials.
Journal ArticleDOI

The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya

TL;DR: Why it took over 32 months from announcing a drug policy change to completing early implementation is examined, finding decisions to abandon failing monotherapy in favour of ACT for the treatment of malaria can be achieved relatively quickly.